Skip to main content
Christopher Lathan, MD, Oncology, Brighton, MA

Christopher Scott Lathan MD MPH MS


Chief Clinical Access and Equity Officer Dana-Farber Cancer Institute Medical Director Dana-Farber Network, Associate Chief Medical Officer Medical oncologist Dana-Farber Cancer Institute Associate Professor, Harvard Medical School

Join to View Full Profile
  • 736 Cambridge St.Brighton, MA 02135

Dr. Lathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2028
  • NH State Medical License
    NH State Medical License 2024 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
  • CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2015, 2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Options Beyond the First Line for Squamous Cell Carcinoma 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

  • Dana-Farber and NeighborHealth Partner to Expand Cancer Care Access for Underserved Communities
    Dana-Farber and NeighborHealth Partner to Expand Cancer Care Access for Underserved CommunitiesNovember 13th, 2025
  • The Leukemia & Lymphoma Society (LLS) Invests Nearly $5 Million in Research Committed to Increasing Clinical Trial Access & Participation
    The Leukemia & Lymphoma Society (LLS) Invests Nearly $5 Million in Research Committed to Increasing Clinical Trial Access & ParticipationJuly 9th, 2025
  • Cancer Diagnostic Services Offered at a Community Health Center May Speed Diagnoses for Underserved Patients
    Cancer Diagnostic Services Offered at a Community Health Center May Speed Diagnoses for Underserved PatientsMarch 22nd, 2023

Grant Support

  • Racial Disparities In The Treatment Of Lung Cancer In African AmericansNational Cancer Institute2007–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: